Crossmark

CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy

Crossref DOI link: https://doi.org/10.1186/s41747-023-00380-7

Published Online: 2023-11-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Ye

Lv, Xinna

Wang, Yichuan

Xu, Zexuan

Lv, Yan

Hou, Dailun
Funding

Funding for this research was provided by:

Beijing Tongzhou district science and technology project (KJ2022CX089)

Leading Talents of Beijing Tongzhou District High Level Talent Development Support Project (YHLD2019029)
License Information

Text and Data Mining valid from 2023-11-02

Version of Record valid from 2023-11-02
More Information

Article History

Received: 18 July 2023

Accepted: 31 August 2023

First Online: 2 November 2023

Declarations

:

: This study was approved by the Ethics Committee of Beijing Chest Hospital, Capital Medical University (September 13, 2022/YJS-2022–27). All methods were carried out in accordance with the Declaration of Helsinki guidelines and regulations. The Ethics Committee of Beijing Chest Hospital, Capital Medical University, approved all the data in the study for retrospective analysis and waived the demand for informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below